[1] |
徐欣,黄仁华,周狄,等. 血清β-CTX和OST在骨转移放疗中的临床研究[J]. 临床肿瘤学杂志,2013,18(1):25-29.
|
[2] |
孙燕,管忠震,廖美琳,等. 肺癌骨转移诊疗专家共识(2014版)[J]. 中国肺癌杂志,2014,17(2):52-72.
|
[3] |
LUMACHI F,SANTEUFEMIA DA,DEL CONTE A,et al.Carboxy-terminal telopeptide(CTX) and amino-terminal propeptide(PINP) of type Ⅰ collagen as markers of bone metastases in patients with non-small cell lung cancer[J]. Anticancer Res,2013,33(6):2593-2596.
|
[4] |
王亚萍,黄璇,卢志贤. 血清β-CTX和Total-PⅠNP联检在前列腺癌骨转移监测中的价值[J]. 放射免疫学杂志,2011,24(4):435-437.
|
[5] |
SALEM AM,ZOHNY SF,ABD EL-WAHAB MM,et a1. Predictive value of osteocalcin and beta-CrossLaps in metastatic breast cancer[J]. Clin Biochem,2007,40(16-17):1201-1208.
|
[6] |
刘婷智,王艳玲,吴海鹰,等. 骨标志物N-MID、β-CTX在晚期肺癌骨转移患者中临床意义[J]. 医学信息,2011,24(2):3-4.
|
[7] |
RAMANKULOV A,LEIN M,KRISTIANSEN G,et al.Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer[J]. Prostate,2007,67(3):330-340.
|
[8] |
SEHINDLER F,LAJOLO PP,PINCZOWSKI H,et al.Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours[J]. Eur J Cancer Care(Engl),2008,17(2):152-156.
|
[9] |
伍建蓉,郑玲,杨红,等. 全身骨显像联合血清骨型碱性磷酸酶诊断肺癌骨转移[J]. 肿瘤研究与临床, 2011,23(5):318-320.
|
[10] |
李晶,朱筠. 维生素D与肿瘤相关疾病的研究进展[J]. 新疆医科大学学报,2009,32(2):222-224.
|
[11] |
陈国军,陆建红,董长林,等. 血清ICTP检测对肺癌骨转移的诊断价值及预后评估[J]. 武警医学,2012,21(2):120-122.
|
[12] |
TANG C,LIU Y,QIN H,et al.Clinical significance of serum BAP,TRACP 5b and ICTP as bone metabolic markers of bone metastasis screening in lung cancer patients[J]. Clin Chim Acta,2013,426:102-107.
|
[13] |
史周印,孙杰,潘赛英,等. 检测NTx、BSP 对唑来膦酸治疗肺癌骨转移的临床意义[J]. 现代肿瘤医学,2011,19(3):470-472.
|
[14] |
李殿波,姜格宁. 肺肿瘤标志物及碱性磷酸酶对肺癌骨转移早期诊断的临床意义[J]. 医学综述,2015,22(8):1487-1488.
|
[15] |
OOI LL,ZHOU H,KALAK R,et al.Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis[J]. Cancer Res,2010,70(5):1835-1844.
|